You're right that the industry should do better than it does, but the evidence shows that non-industry sponsors are actually worse at compliance with these reporting rules, than industry sponsors. [0]
[0] https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
Sure but who does most of the research, especially of new drug/compounds?
According to Goldacre et al [0] from the 4209 trials included in their analysis, 2178 (51.8%) were non-industry, 1837 (43·6%) were sponsored by industry, and 194 (4·6%) were sponsored by the US Government.
So a (modest) majority were sponsored by non-industry.
[0] https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
Industry does. Industry R&D spend is almost double that of gov’t spend. Academia does most of the basic science.
There are a lot of great people in this industry but the incentives are often so horribly misaligned against consumers’ best interests that it is shocking.